Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-21
    E.g., 2018-09-21

Articles

51709 items
12:00 AM, Sep 14, 2000  |  BC Extra | Company News

Applied Molecular Evolution grants Idexx sub-license

IDXX received a non-exclusive sub-license for AMEV's Kauffman patents for directed evolution. The patents cover methods of stochastically generating proteins, which AMEV believes is required by many directed evolution technologies. IDXX will use the patents...
12:00 AM, Sep 14, 2000  |  BC Extra | Company News

Cyclacel acquires Fluorescience

Cyclacel acquired Fluorescience (Leeds, U.K.), a developer of fluorescence assays for use primarily in the kinase field, for cash. Cyclacel (Dundee, U.K.) said the acquisition will complement its assays and enhance its cancer drug discovery...
12:00 AM, Sep 14, 2000  |  BC Extra | Company News

Schwarz in CNS deal

Schwarz Pharma (Monheim, Germany) and the neurology center of the Universitatsklinikum Freiburg (Freiburg, Germany) will jointly develop compounds for neurodegenerative diseases. Schwarz will have worldwide rights to the compounds, which are in preclinical development....
12:00 AM, Sep 14, 2000  |  BC Extra | Company News

Agritope plant transformation deal with Rohm and Haas

The companies will combine AGTO's visual marker gene technology with ROH's ligand-inducible gene expression technology to develop a plant transformation marker selection system. ROH will contribute its synthetic ecdysone receptors and ligand inducer chemistry for...
12:00 AM, Sep 14, 2000  |  BC Extra | Clinical News

Emisphere enrollment less than expected

EMIS said that it will not complete by year end its double-blind Phase III trial comparing its oral heparin with Lovenox from Aventis (AVE) to treat deep vein thrombosis. The company had initially targeted 95...
12:00 AM, Sep 14, 2000  |  BC Extra | Company News

Proteome and Celera collaborate

Proteome will license its BioKnowledge Library to CRA for distribution through the Celera Discovery System. BioKnowledge is a collection of searchable databases that contain annotated information on proteins from organisms, including humans, worms and yeast....
12:00 AM, Sep 14, 2000  |  BC Extra | Company News

CAT and Wyeth-Ayerst in Alzheimer's deal

Cambridge Antibody Technology (LSE:CAT) granted Wyeth-Ayerst, a division of American Home Products (AHP), an exclusive license to develop antibody therapeutics specific for the amyloid beta peptide associated with Alzheimer's disease. CAT will receive a license...
12:00 AM, Sep 14, 2000  |  BC Extra | Company News

Lexicon licenses GeneChips from Affymetrix

LEXG will combine AFFX's GeneChips with its knockout mouse technology for use in its internal oncology program, initially focusing on the Ku80 gene for DNA repair. LEXG will evaluate targets in the Ku80 pathway, which...
12:00 AM, Sep 14, 2000  |  BC Extra | Clinical News

Maxim puts out Phase II Maxamine data

MAXM announced results from its 48-week, 129-patient, European, Israeli, and Russian dose escalation trial of Maxamine histamine dihydrochloride in combination interferon-alpha (INF-a) to treat chronic hepatitis C infections. MAXM said 61 percent of patients on...
12:00 AM, Sep 14, 2000  |  BC Extra | Politics & Policy

Re-importation of prescription drugs top priority

A bipartisan group of Senators and Representatives today blasted the pharmaceutical industry's opposition to the re-importation of prescription drugs and said enactment of re-importation legislation will be their top priority as the current Congressional session...

Pages